Form 4: Allovir Inc. Chief Accounting Officer Brett Hagen Reports Stock Sale to Cover Tax Obligations
SEC Form 4 Filing
Brett Hagen, Chief Accounting Officer of Allovir, Inc., sold shares of common stock on February 21, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 21, 2025, Brett Hagen, the Chief Accounting Officer of Allovir, Inc., sold 96 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $10.0758, with individual transaction prices ranging from $10.06 to $10.13.
- Following the transaction, Hagen directly owns 2,832 shares of Allovir, Inc. common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document reports a routine stock sale for tax purposes, with no indication of positive or negative implications for the company's performance.
Industry Context
This Form 4 filing is a routine disclosure related to insider stock transactions, common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The stock sale has a minimal impact on shareholders as it is a small transaction related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/21/2025 | Date of stock sale transaction. |
| 02/24/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.